On June 14, 2007, Mark Waxman presented at an AdvaMed MTLI Audio Conference on “CME Programs – Guidelines and Pitfalls for Sponsorship and Support.”
Topics discussed included the following:
- Why sponsor CME programs? What are the benefits to providers and to sponsors?
- What is the dividing line between education and promotion?
- What are the differences between formal CME programs and non-physician continuing education programs with manufacturer involvement?
- What are the risks of off-label promotion?
- What control does a sponsor have over CME program content?
- How does one draft the most equitable and productive Letter of Agreement between industry sponsors and CME providers?
- How can companies reduce their exposure to regulatory concerns?
Speakers:
- Sandy C. Kalter, Senior Legal Director and FDA Counsel, Corporate Legal/Regulatory, Medtronic, Inc.
- Sue Seferian, Senior Counsel, Johnson & Johnson
- Mark Waxman, Partner, Foley & Lardner LLP
Related Insights
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.
June 3, 2025
Health Care Law Today
Risk Bearing Entity Requirements: Massachusetts
This blog discusses the regulatory requirements that apply to risk-bearing entities in Massachusetts, including recent updates introduced by Chapter 343 of the Massachusetts Acts of 2024.
June 2, 2025
Labor & Employment Law Perspectives
Update on DHS Efforts to Terminate TPS and Parole Status for Various Immigrant Groups
The U.S. Department of Homeland Security (DHS) has been actively working to terminate Temporary Protected Status (TPS) and Parole status…